The role of economic evaluation in vaccine decision making Robert WelteCaroline L. TrotterPhilippe Beutels Review Article 17 September 2012 Pages: 855 - 874
Economic implications of biological therapies for Crohn’s disease Keith Bodger Review Article 17 September 2012 Pages: 875 - 888
A systematic review of patient-reported outcome instruments measuring sleep dysfunction in adults Emily Beth DevineZafar HakimJesse Green Review Article 17 September 2012 Pages: 889 - 912
Cost-benefit analysis of vaccination against tick-borne encephalitis among French troops Guillaume DesjeuxLaurent Galoisy-GuibalCyrille Colin Original Research Article 17 September 2012 Pages: 913 - 926
Cost effectiveness of dalteparin for preventing venous thromboembolism in abdominal surgery Adrienne HeereySanjeev Suri Original Research Article 17 September 2012 Pages: 927 - 944
The public financing of pharmaceuticals: An economic approach Eric J. MoskowitzDavid B. Nash Book Review 17 September 2012 Pages: 965 - 965